Skip to main navigation Skip to search Skip to main content

A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Project: Research

Project Details

StatusActive
Effective start/end date23/12/24 → 22/12/29

Clinical Trial Phase

  • Phase III (a & b)